2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Saturday, December 12, 2026
05:30 p.m. - 07:30 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Gene Editing, Profiling, Treatment Considerations, Combination Therapy, Drug Development, Biological Therapies, Antibody Therapy, Transplantation, Immunotherapy, Non-Biological Therapies, Chemotherapy, Pharmacology, Radiation Therapy, Biological Processes, Hematopoiesis, Immune Mechanism, Metabolism, Microbiome, Molecular Biology, Multi-Systemic Interactions, Diseases, Bone Marrow Failure Syndromes, Immunology, GVHD, Lymphoid Malignancies, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Fundamental Science, AML, Translational Research, Study Population, Animal Model
PAPER

2323 Donor DPP4/CD26 loss unmasks age- and sex-dependent hematopoietic and metabolic phenotypes after transplantation

Jimin Park, PhD, Sarah Gutch, PhD2, So Jeong Kim3, Jessica Newton4, Nikhil Nayak5, Lindsay Wathen, MSc6, Maegan Capitano, PhD7, Kok Lim Kua, MD8, James Ropa, PhD9
1 Indiana University School of Medicine, Indianapolis, Indiana, United States
2 Indiana University School of Medicine, Indianapolis, Indiana, United States
3 Indiana University School of Medicine, Indianapolis, Indiana, United States
4 Indiana University School of Medicine, Indianapolis, Indiana, United States
5 Indiana University School of Medicine, Indianapolis, Indiana, United States
6 Indiana University School of Medicine, Indianapolis, Indiana, United States
7 Indiana University School of Medicine, Indianapolis, Indiana, United States
8 Indiana University School of Medicine, Indianapolis, Indiana, United States
9 Indiana University School of Medicine, Indianapolis, Indiana, United States
Background: Aging impairs hematopoietic stem and progenitor cell (HSPC) function and donor bone marrow (BM) fitness, but it remains unclear whether age-associated changes in donor hematopoiesis also affect recipient physiology after transplantation. Dipeptidyl peptidase-4 (DPP4/CD26) regulates hematopoiesis, immune function, and glucose metabolism, and its expression changes with age. We examined whether DPP4 loss alters donor BM function at steady state and after transplantation and whether these effects vary by age and sex.

Methods: Young and aged wild-type (WT) and constitutive DPP4 knockout (DPP4-KO) mice of both sexes were evaluated at steady state and after competitive BM transplantation. At baseline, peripheral blood (PB) and BM were analyzed by multiparameter flow cytometry to characterize mature immune populations and BM HSPC/progenitor subsets. Cell-surface DPP4/CD26 expression was quantified across PB and BM hematopoietic populations. Systemic phenotypes, including body weight, random blood glucose, glucose tolerance, insulin tolerance, and body composition, were also assessed. To evaluate donor BM function under transplantation stress, CD45.2 WT or DPP4-KO donor BM was transplanted together with CD45.1 Boy/J competitor BM. PB donor, competitor, and host contributions, as well as donor-derived lineage output, were monitored from 4 to 32 weeks after transplantation. At week 32, recipients were evaluated for PB and BM hematopoietic output, BM HSPC/progenitor composition, and post-transplant systemic phenotypes.

Results: Cell-surface DPP4/CD26 was not broadly detected across phenotypically defined HSPCs but was enriched in mature lymphoid compartments, particularly CD8+ T cells and B cells, while remaining low in neutrophils. Its expression declined with age in both PB and BM, indicating dynamic regulation during hematopoietic aging. At steady state, the hematopoietic effects of DPP4 deficiency varied by age and sex, affecting mature immune-cell composition and the BM HSPC/progenitor compartment, including HSC, MPP2, and MPP3 populations. Aged female DPP4-KO mice also showed impaired insulin sensitivity and increased pancreatic beta-cell area, indicating early sex-specific metabolic dysregulation. Notably, this steady-state phenotype did not fully predict post-transplant outcomes, as glucose-related changes in recipients were most consistent in male mice.
After competitive transplantation, DPP4-KO donor BM produced age- and sex-dependent differences in hematopoietic balance, body-weight trajectories, and glucose-related phenotypes. At week 32, male recipients of DPP4-KO donor BM showed consistent glucose dysregulation, evident in both random glucose and glucose tolerance testing, primarily in young mice, whereas female recipients showed a more restricted increase in random glucose limited to aged mice. These findings suggest that donor BM DPP4 status is associated with recipient metabolic physiology after transplantation.
Longitudinal PB monitoring from weeks 4 to 32 also revealed age- and sex-dependent differences in donor, competitor, and host contributions, indicating that DPP4 deficiency altered post-transplant hematopoietic balance over time. At week 32, PB and BM analyses confirmed persistent differences in donor-derived hematopoietic output, including BM engraftment, mature lineage distribution, and myeloid-to-lymphoid balance. BM HSPC/progenitor differences were most apparent in male recipients. Overall, DPP4 loss remodeled age-associated hematopoiesis at baseline, whereas transplantation revealed broader hematopoietic and systemic phenotypes.

Conclusions: These findings identify DPP4/CD26 as an age- and sex-dependent regulator of donor hematopoiesis and post-transplant systemic physiology. Although the initial hypothesis focused on age-associated donor hematopoiesis, DPP4/CD26 loss in donor BM was also associated with recipient-level systemic phenotypes, including body-weight differences and sex-divergent glucose responses. Together with the persistent changes in donor-derived hematopoietic output, these findings suggest that DPP4/CD26 serves as a mechanistic bridge between donor hematopoietic aging and recipient metabolic physiology after transplantation.
Jimin Park, PhD: No relevant conflicts of interest to declare.